|
Volumn 62, Issue 8, 2016, Pages 1054-1060
|
Circulating tumor DNA as a cancer biomarker: Fact or fiction?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL FREE DNA;
CIRCULATING TUMOR DNA;
DNA;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ANEUPLOIDY;
APOPTOSIS;
CANCER SURGERY;
CANCER THERAPY;
CELL DESTRUCTION;
CELLULAR SECRETION;
CIRCULATING TUMOR CELL;
CLINICAL PRACTICE;
COMPARATIVE GENOMIC HYBRIDIZATION;
DNA METHYLATION;
DNA SEQUENCE;
EXOME;
GENOTYPE;
HISTOPATHOLOGY;
HUMAN;
MINIMAL RESIDUAL DISEASE;
NECROSIS;
NONHUMAN;
PERSONALIZED MEDICINE;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PROGRESSION FREE SURVIVAL;
SHORT SURVEY;
SOMATIC MUTATION;
TRANSLATIONAL RESEARCH;
TREATMENT RESPONSE;
TUMOR BIOPSY;
TUMOR BLOOD FLOW;
TUMOR MICROENVIRONMENT;
TUMOR VOLUME;
NEOPLASM;
PATHOLOGY;
TUMOR EMBOLISM;
BIOMARKERS, TUMOR;
CIRCULATING TUMOR DNA;
HUMANS;
NEOPLASMS;
NEOPLASTIC CELLS, CIRCULATING;
|
EID: 84980011885
PISSN: 00099147
EISSN: 15308561
Source Type: Journal
DOI: 10.1373/clinchem.2016.260331 Document Type: Short Survey |
Times cited : (89)
|
References (0)
|